doi: 10.3389/fmed.2026.1752341 Received 23 November 2025 Revised 04 April 2026 Accepted 10 April 2026 Published 29 April 2026 Volume 13 - 2026 Edited by Wei Liu, Huazhong University of Science and Technology, China Reviewed by Jheng-Yan Wu, Chi Mei Medical Center, Taiwan Jennifer Teske, University of Arizona, United States Updates Copyright 2026 Fang, Zhu, Rao and Liu
GLP-1s are distinct from previous classes of prescription weight loss drugs such as phentermine, as they target essential metabolic pathways
1 Introduction Glucagon-like peptide-1 (GLP-1) is a gut peptide hormone that functions as an incretin that plays a key role in controlling satiety and various other physiological functions
Here is what it does: Tells your pancreas to release insulin, which lowers blood sugar Slows how fast your food leaves your stomach, so you feel full longer Sends signals to your brain to reduce feelings of hunger Some weight-loss and diabetes medications are called GLP-1 receptor agonists, which means they copy this natural hormone and boost its effects
53) and trained with baseline and example nests
Modern Restaurant Management [MRM]
